DDX3X and breast carcinoma: Downregulation of DDX3X promotes stem cell-like properties and tumorigenesis in hepatocellular carcinoma cells [37], while the upregulation of DDX3 was observed in distant breast cancer metastases and correlated with poor prognosis [38, 39].